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Abstract   
With over 100 common variants associated with schizophrenia risk, establishing the biological 
significance of these variants is a priority. We sought to establish the cognitive effects of risk 
variants at gene loci implicated in synaptic transmission by 1) identifying GWAS 
schizophrenia variants whose associated gene function was identified as related to synaptic 
transmission, and 2) testing for association between these variants and measures of 
neurocognitive function. We selected SNP variants, reported in the largest genome-wide 
association study to date, located within ~20kb of genes associated with synaptic transmission. 
Associations between genotype and cognitive test score were analyzed in a discovery sample 
of 798 Irish patients with psychosis and 190 healthy participants, and replication samples (528 
UK participants; 921 German participants). Three loci showed significant associations with 
neuropsychological performance in the discovery samples. This included an association 
between rs2007044 within CACNA1C and poorer working memory performance (increase in 
errors – B [95% CI] = 0.635 – 4.535, p=0.012). In an fMRI analysis of working memory 
performance (n=103 healthy participants), we further found evidence that the same CACNA1C 
risk allele G was associated with decreased functional dysconnectivity between the right 
dorsolateral prefrontal cortex and both the right anterior cingulate and cuneus. In conclusion, 
these data provide some evidence to suggest that the CACNA1C risk variant rs2007044 is 
associated with poorer memory function, and that this may result from risk carriers’ difficulty 
with top down initiated responses caused by dysconnectivity between the right DLPFC and 
three cortical regions.  
Key Words: genetics, GWAS, fMRI, RIMS1, CACNB2 
Cosgrove et al. 
3 
 
Introduction  
Predictions that increasing sample sizes would also lead to an increase in genome wide 
significant schizophrenia (SZ) risk variants being identified1 have been supported to date. As 
sample sizes available for GWAS have increased, the numbers of significantly associated 
common variants and genes has gone from one, ZNF804A2, to a handful3 to over 108 loci now 
being implicated4. As the purpose of gene discovery is to identify the biological pathways that 
increase risk and are capable of being targeted by treatments, moving from discovering to 
establishing functional impact is a priority for our field.  
While this is often thought of at the molecular and cellular level, establishing the functional 
impact of genes and gene sets at other levels of analysis (i.e. neural, cognitive, and behavioral) 
is also likely to be important in providing insights for new treatment discovery. For example, 
we and others have previously sought to establish the cognitive effects of polygenic risk in 
pathways defined either by biological processes, e.g. variants within the cell adhesion molecule 
pathway5, or by gene sets functionally related to identified SZ-risk genes (e.g. ZNF804A)6. To 
date, and to our knowledge, however, no study has systemically investigated the cognitive 
effects of SZ variants for synaptic transmission despite the fact that alterations in this process 
(and neurotransmitter systems, e.g. dopamine) have long been held as a key etiological 
hypothesis for both SZ risk and for deficits in cognition associated with the disorder7-9. Looking 
at the effect of SZ-associated variants on cognition may help identify specific neurobiological 
processes involved, so as to allow this aspect of disability to be more effectively targeted.  
The purpose of the present study was to undertake a systematic analysis of the cognitive effects 
of SZ risk associated variants identified by the Schizophrenia Working Group of the Psychiatric 
Genomics Consortium (PGC-SCZ)4 in genes related to synaptic transmission using a novel 
methodology. We did this by 1) cross-referencing PGC-SCZ identified variants whose 
associated gene function was bioinformatically identified as related to synaptic transmission 
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using OMIM and Gene Ontology, and 2) comparing the performance of carriers and non-
carriers of these variants on cognitive functions typically impaired in SZ. Our hypothesis was 
that the identified risk variants at these gene loci would be associated with poorer performance 
on measures of cognition. 
Cosgrove et al. 
5 
 
Methods  
 
Neuropsychological Sample Characteristics  
  
Cognitive performance was assessed in 939 cases and 330 healthy participants (769 males, 500 
females).  Cases consisted of clinically stable patients with either a ‘narrow sense psychosis’ 
diagnosis of SZ or schizoaffective disorder (SZA) (n=676) or a ‘broader sense psychosis’, 
which in addition to our SZ/SZA sample, included patients with a  diagnosis of bipolar disorder 
with psychotic features, major depressive disorder with psychotic features, or psychosis not 
otherwise specified (n=263), based on Structured Clinical Interview for DSM-IV Axis I10. 
Healthy participants were recruited from the general population through local media 
advertisements and satisfied, on the basis of clinical interview, the criteria of having no history 
of major mental health problems or intellectual disability, and no first-degree relative with a 
history of psychosis. All participants were aged between 18 and 65 years and had Irish-born 
paternal and maternal grandparents, no acquired brain injury, and no substance abuse in the 
preceding six months. All assessments were conducted in accordance with the relevant ethics 
committees’ approval (St. James's Hospital, Tallaght Hospital, Galway Hospital, Cork 
Hospital, and Beaumont Hospital Research Ethics Committees), and all participants provided 
written informed consent. A significant proportion of these samples were previously included 
in the PGC-SCZ GWAS4.  
Two replication samples were also available. Samples from Cardiff consisted of 528 European 
Caucasian individuals with SZ or SZA who were recruited from community mental health 
teams in Wales and England. A SCAN interview and case note review were carried out to 
confirm diagnosis according to DSM-IV criteria. The UK Multicenter Research Ethics 
Committee (MREC) approved the study, and all participants provided valid informed consent.  
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The German replication sample consisted of 362 clinically stable patients with a DSM-IV 
diagnosis of SZ, and 559 healthy controls, all genotyped as part of a previous study2. All 
participants provided written informed consent, were aged between 18 to 80 years, and had no 
history of head injury or neurological diseases. Patients were included if they had a DSM-IV 
diagnosis of SZ, whereas healthy controls underwent interviews to confirm the absence of any 
lifetime psychotic disorder or those who had first-degree relatives with psychotic disorders. 
Healthy participants underwent an extensive screening process described elsewhere11 and all 
were European Caucasian.   
Demographic variables available for all samples included age, gender and years of education. 
For patients, both clinical symptom severity (measured using the Scale for the Assessment of 
Positive Symptoms (SAPS) and the Scale for the Assessment of Negative Symptoms (SANS) 
and medication dosage in terms of chlorpromazine equivalents (CPZ) were also available, as 
previously described11. 
fMRI Spatial Working Memory Task Sample Characteristics 
A subgroup of the healthy participants (n=103, all right handed) had also undergone functional 
imaging during performance of an fMRI spatial working memory task. This task, and the 
acquisition parameters used, has been extensively used by us previously12-14 (see Appendix I 
for fuller description).  This task required participants to identify whether a white dot was in 
the same spatial location as a red circle over a three-second delay. 
 
Candidate SNP Selection 
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 A novel approach was taken to gene selection in this study. Gene function was assigned to 
PGC2 identified genes4 using the OMIM15 and Uniprot16 catalogues (Supplementary Table 
1). Genes associated with the processes of neurotransmission, neurotransmitter secretion or 
transduction were identified by the lead author. Following this, 28 genes functioning in 
synaptic transmission were prioritized. We identified SNPs within 20kb of these genes, initially 
by visual inspection of the supplementary regional GWAS association plots from the PGC-
SCZ4. This exercise shortlisted loci where the genome-wide significant association signal was 
at or close to a synaptic transmission gene (n=11). For these loci we identified the most 
significant GWAS SNP (the index SNP) as the variant for use in our cognition analyses. In the 
case of CACNA1C multiple GWAS signals relating to two LD blocks were identified; for this 
reason two SNPS were included in the analysis, representing the strongest signal for each LD 
block. To confirm cis effects of these SNPs on the proposed associated genes, the Braineac17 
and Ensembl18 databases were consulted. Finally, to bioinformatically confirm functional 
identity, this list of genes was entered into GO and found to have >98 fold enrichment in 
chemical synaptic transmission (GO: 0099565). Based on this approach the following variants 
were identified: rs2007044 and rs2239063 (CACNA1C), rs7893279 (CACNB2), rs8042374 
(CHRNA3), rs10520163 (CLCN3), rs2514218 (DRD2), rs9922678 (GRIN2A), rs12704290 
(GRM3), rs1501357 (HCN1), rs1339227 (RIMS1), and rs4523957 (SRR). All of these SNPs are 
located within introns at these respective genes except for RIMS1 and DRD2 where the index 
SNPs are located in flanking regions17, 18. The gene RIMS1 is located further away (~50kb) 
from the index SNP, however, we still included it in the analysis as it met all other criteria. 
 
Neuropsychological Assessment 
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The second stage in the study was to undertake a cognitive analysis of the variants identified 
above, seeking replication of significant findings in independent samples. A full 
neuropsychological assessment, designed to evaluate the cognitive deficits typically reported 
in SZ (with five cognitive domains - general cognitive function, episodic and working memory, 
attention, and social cognition) was administered to each participant. Selected subtests 
(Vocabulary, Similarities, Block Design, and Matrix Reasoning) of the Wechsler Adult 
Intelligence Scale (WAIS III)19 were used to measure general cognitive function. The Logical 
Memory and Faces subtests from the Wechsler Memory Scale (WMS III)20 were used to assess 
verbal and visual memory recall. Working memory was assessed using the Spatial Working 
Memory (SWM) task taken from the Cambridge Automated Neuropsychological Test Battery 
(CANTAB) and the Letter-Number Sequencing subtest from WAIS III. Attentional control 
was assessed using the Continuous Performance Task (CPT)21 and the Sustained Attention to 
Response Task (SART)22. Social cognitive function was assessed using three measures of 
social cognition: two Theory of Mind (ToM) tests and one attributional style test. ToM is the 
ability to attribute mental states – beliefs, intents, desires, pretending, knowledge, etc. – to 
oneself and others23. The ToM tests used were the Reading the Mind in the Eyes test (Eyes)24 
and the Hinting Task (Hint)25. Attributional style was measured using the Internal, Personal, 
Situational Attributions Questionnaire (IPSAQ)26. This refers to the pervasive tendency to 
explain personally significant positive or negative events in a particular manner, i.e. the degree 
to which events can be attributed to oneself or to external causes. The discovery dataset is based 
on a number of data collection waves. Social cognition was only included in the more recent 
waves of recruitment, resulting in smaller N size available for these tasks. 
All individuals in the Cardiff sample were assessed using the MATRICS Consensus Cognitive 
Battery27. This includes seven cognitive domains: speed of processing, attention/vigilance, 
verbal and nonverbal working memory, verbal and visual memory, reasoning and problem 
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solving. Of note, the social cognition domain included in the MATRICS was not a measure of 
ToM (unlike in the Irish samples) but rather an index of emotional self-regulation. 
In the German sample, IQ was measured using the German version of the WAIS Revised28, 
while memory and attention was assessed using subtests from the German WMS Revised29, 
the N-back30, 31, and the Continuous Performance Test, 3-7 Version32, respectively. These 
measures were selected on the basis of closely approximating the measures available in the 
Irish samples; unfortunately, measures of social cognition were not available for the German 
samples. Supplementary Table 2 provides more detailed description of neuropsychological 
tests used in each sample. 
Genotyping  
Genotyping was performed on DNA extracted from whole blood or saliva on a subset of 
participants who underwent neuropsychological testing. Full GWAS data was available for 988 
participants (healthy participants n=190; SZ/SZA=578; other psychoses n=220). Previous 
analysis of the Irish GWAS sample used in the study indicated that the sample is homogenous 
33
 in terms of population stratification. Age and gender of those with genotype information did 
not differ from that of the whole sample. A proportion of samples were genotyped with an 
Affymetrix 6.0 chip and the remainder on the Illumina HumanCoreExome chip. SNPs were 
excluded on the basis of MAF<0.1%, SNP missingness ≤2%, Hardy-Weinberg equilibrium 
p≤10-6, the analysis for which was carried out using PLINK34. Imputation was carried out on 
these datasets separately using 1000 Genomes Phase I integrated haplotypes (Dec 2013 release) 
and IMPUTE2 to give ~10 million SNPs genome-wide per sample. Genotyping for the Cardiff 
and German samples was as previously described35.  
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Statistical Analysis 
Analysis of Neuropsychological data All neuropsychological analyses were carried out using 
SPSS 2036. To estimate risk variant effects on cognitive deficits associated with SZ, linear 
regression analyses were performed on the total sample (i.e. irrespective of diagnosis, n=988). 
To test associations between genotype and cognitive test score, hierarchical multiple regression 
with bootstrapping was performed (1000 iterations, with replacement, to identify a bias 
corrected and accelerated 95% confidence interval). In each case cognitive test score was 
entered as a dependent variable, age and sex were entered as predictors on the first step, 
followed by genotype on the second step. As this initial discovery sample analysis was carried 
out in order to identify any significant or nominally significant findings, a correction for 
multiple testing was not applied. Instead, nominally significant findings from cognitive 
analyses were taken forward for analysis to seek replication in two independent samples. 
Where replication of results was found in these independent samples, the associated SNPS were 
taken forward for neuroimaging analysis.  
Analysis of fMRI data: Pre-processing and statistical analysis are detailed in Appendix I.  
First-level analysis included working memory (1 dot and 3 dots > baseline), and increased 
memory load (3 dots > 1 dot) contrasts. The 1 dot and 3 dots > baseline contrast considered 
both the 1 dot and 3 dot conditions together (i.e. all of the spatial working memory blocks) and 
contrasted all of these blocks against the baseline blocks (the blocks during which there was 
no delay between the white dot and red circle).  The 3 dots > 1 dot condition considered the 3 
dots blocks and contrasted these against the 1 dot blocks to examine increasing blood-oxygen-
level dependent (BOLD) response associated with increasing working memory load (i.e. 
remembering the location of 3 white dots compared to remembering the location of 1 white 
dot). Contrast maps were entered into a multiple regression analysis with number of risk alleles 
as covariate of interest. 19 participants were excluded due to low quality or missing data 
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(Appendix I).  Seed voxel correlation analysis was used to examine functional connectivity 
using the right dorsolateral prefrontal cortex (DLPFC) as a seed.  Eigenvariates extracted from 
this seed were entered into a first level analysis and resulting connectivity maps entered into a 
multiple regression analysis. Results were examined at a p<0.001 (uncorrected) level and 
clusters were considered statistically significant at a p<0.05 level, family-wise error (FWE) 
corrected for multiple comparisons across the whole brain at the cluster level.  Masks used for 
functional connectivity analysis were kindly provided to us by Esslinger & Paulus based on 
Paulus et al.37 Functional connectivity analysis was examined using both ‘global maximum’ 
and ‘next local maximum’ seed selection methods to examine whether results were consistent 
across both methods38 (Appendix I). The rationale for carrying out this connectivity analysis 
is that genetic effects may be more penetrant at a cortical level than a behavioral level, as we 
and others have previously shown for schizophrenia risk variants37, 39. 
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Results   
Neuropsychological Samples - Demographic and Clinical Characteristics.  
For the cognitive measures employed, healthy participants scored higher than patients on all 
measures of IQ, attention and social cognition used in analysis except for Externalizing Bias 
(ANCOVA; covariates age and gender, p<0.0001; Table 1). There was a significant difference 
in age between the rs9922678 (GRIN2A) allele groups only (F=4.28, p<0.05; Mean values 
GG=41.15, GA=42.44, AA=38.28). No other between group differences were observed.  
When genotype groups were compared on demographic variables, no significant between- 
group differences were observed for any SNP included for either gender or years of education 
(p>0.05). No between group differences were observed for diagnosis status or total positive 
symptom severity scores (SAPS total scores) for any SNP. For symptoms, DRD2 rs2514218 
risk genotype showed significantly higher negative symptoms (F=3.67, p<0.05; Mean values 
TT=18.61, CT=23.78, CC=25.69). No medication dosage (measured in terms of 
chlorpromazine equivalents), or other genotype related clinical differences were observed. 
Demographic and clinical characteristics for patients and healthy participants are presented in 
Table 1. A between comparison of these groups indicated differences between the healthy 
participants and both broad and narrow groups in terms of age, gender and education. 
Supplementary Table 3 shows additional summary statistics and results comparing genotype 
group demographics. No age or sex associations were observed with rs2007044 in either the 
Cardiff or German sample.  
>>Table 1<< 
 
Effect of Genotype on Cognition 
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Of 11 SNPS included, significant effects were observed in the discovery sample (cases and 
controls) for three SNPS (Table 2 presents the three SNPs with significant results in all 
participants and subgroups). For rs2007044 (located within the Calcium Channel Subunit 1AC 
gene; CACNA1C), increased risk ‘G’ allele dosage was associated with increased errors made 
on the CANTAB spatial memory task, explaining a proportion of test score variance in the 
entire sample (B=2.6, r2=0.006, p<0.05). In a post hoc analysis to explore whether or not the 
signal was driven by specific patient subgroups, in the broad psychosis group, the same 
direction of effect was observed (B=3.634, r2=0.012, p<0.01). This was also the case in the 
narrow psychosis group (SZ and SZA patients only) (B=3.578, r2=0.011, p<0.05; see Table 2). 
No significant association was observed in healthy participants when considered alone. 
However, the same direction of association, i.e. reduced working memory performance in risk 
carriers, was observed. The same analysis was re-run in patients by including CPZ as a co-
variate; this did not affect the significance of the results observed. No association between 
verbal working memory, as measured by Letter-Number Sequencing task and rs2007044 was 
observed. 
For the SNP rs7893279 (located within the gene encoding the Calcium Channel Subunit B2; 
CACNB2) increased risk ‘T’ allele dosage was associated with lower accuracy on the Hinting 
Task, a measure of ToM ability (B=-0.772, r2=0.012, p<0.01). When the broad psychosis group 
was considered separately, this association remained significant (B=-0.643, r2=0.006, p<0.05). 
This association also remained significant in the narrow psychosis group (B=-0.826, r2=0.009, 
p<0.05) and in the healthy sample (B=-0.895, r2=0.052, p<0.01). No associations with other 
social cognition measures, or measures of other cognitive domains were observed. 
For rs1339227 (located ~50kb from RIMS1, the only known gene at this locus) increased risk 
‘C’ allele dosage was, contrary to our expectation, associated with improved Eyes Task 
performance, another measure of ToM ability (B=0.831, r2=0.008, p<0.05). When the broad 
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psychosis group was considered separately, this association remained significant (B=1.272, 
r2=0.018, p<0.01). This association remained significant also in the narrow psychosis group 
with the amount of variance explained increasing (B=1.807, r2=0.034, p<0.01), suggesting that 
the genotype effects were more pronounced in this group. No significant association was 
observed in the healthy participants sample only. 
>> Table 2<< 
Replication Analysis 
 
We sought replication of our spatial working memory and rs2007044 risk G genotype 
association (uncorrected). In the Cardiff replication sample (consisting of patients only), we 
sought to replicate this association between CACNA1C and working memory using the working 
memory domain score (calculated from both the Wechsler Memory Scale Spatial Span subtest 
and the Letter-Number Span subtest) from the MATRICS battery. Based on this analysis (three 
genotype groups AA, AG, GG), increased rs2007044 risk ‘G’ allele dosage was again 
associated with decreased working memory accuracy (B=-0.157, r2=0.01; p=0.03). Because 
the working memory domain score in the MATRICS is composed of a verbal (letter number 
sequencing) and spatial (Spatial Span), we conducted a post hoc analysis to establish whether 
our result was being driven by either the verbal or spatial subtest. This analysis suggested that 
the association observed was driven by the verbal subtest performance (Letter number 
sequencing: B= –0.200, 95% CI -0.358 – -0.042, p=0.013) as the spatial subtest by itself was 
non-significant (Spatial Span: B= –0.089, 95% CI -0.222 – 0.045, p=0.192). 
In the German samples, two working memory measures were available. The first consisted of 
performance on an n-back test (1- and 2-back), and a composite working memory score based 
on the Wechsler Digit Span and Spatial Span Tasks. Based on the same analysis undertaken as 
in the Irish and Cardiff sample, a main effect of CACNA1C genotype for the n-back test (2-
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back condition only) such that the risk ‘G’ genotype carriers scored significantly below the 
non-risk carriers in the patients but not in controls (B=2.615, r2=0.012; p=0.03). Furthermore, 
the CACNA1C variant was associated with cases only and not healthy participants, and neither 
was an association between CACNA1C and the composite Digit/Spatial Span score observed.  
Finally, for the associations between social cognition and CACNB2 (Hinting task performance) 
and RIMS1 (Eyes task performance), neither risk variant was associated with social cognition 
as indexed by the MSCEIT ‘managing emotions’ subtest in the Cardiff samples, and no social 
cognition data was available in the German dataset. 
 
fMRI Spatial Working Memory Analysis 
Since we observed an effect of the rs2007044 risk ‘G’ genotype on working memory in two 
replication samples as well as our own, we also brought this SNP forward to investigate 
whether or not there was an association with altered connectivity during a spatial working 
memory fMRI task. There were no significant differences between genotype groups for age, 
years of education, spatial working memory accuracy, spatial working memory reaction time 
or gender in the MRI sample (p>0.05) (Table 3). 
>>Table 3<< 
 
Neural Activity Associated with Spatial Working Memory Performance in Healthy 
Participants 
Spatial working memory (1 dot and 3 dots combined) was associated with significantly 
increased neural activation in the fronto-parietal attention network across our sample 40, 41 
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including, bilaterally, the dorsolateral prefrontal cortex (BA 9 and 46; tmax(84) = 19.48; p<0.05 
corrected; see Appendix I).  In addition, the 3 dots condition was associated with increased 
activity across several of these frontal and parietal regions compared to the 1 dot condition 
(tmax(84) = 12.99; p<0.05, corrected; see Appendix I). There were no significant differences 
between genotypes on either contrast, i.e. genotypes did not influence BOLD response for the 
spatial working memory task. 
Functional Connectivity Analysis 
Decreased functional connectivity was associated with risk genotype, between the right 
DLPFC and three clusters incorporating the right cuneus, right anterior cingulate cortex, and 
left inferior frontal gyrus (tmax(82)=5.32; p<0.05, corrected; see Appendix I). As a QC measure, 
average parameter estimates were calculated for each individual, based on which five outliers 
were identified; after removing these outliers however findings were largely unchanged, with 
altered connectivity between the DLPFC and the right superior occipital gyrus/right cuneus 
and the right anterior cingulate cortex remaining significant (tmax(77) =4.92; p<0.05, corrected; 
see Table 4 and Figure 1). Finally, we examined functional connectivity of the right DLPFC 
across our sample using the ‘next local maximum’ approach (see Appendix 1).  Results of this 
analysis were again supportive of the main analysis, with altered connectivity between the 
rDLPFC and occipital and cingulate clusters observed, albeit at a lower threshold (p<0.001, 
uncorrected). 
>> Table 4 << 
>> Figure 1 << 
Discussion 
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In this study we assessed the effects of 11 SZ-associated SNPs linked with synaptic 
transmission genes on behavioral and cortical measures of cognition. Three SNPs were found 
to be significantly associated with neuropsychological test scores, two of which are linked to 
calcium channel genes, and one with vesicular trafficking. Carriers of the SZ-associated risk 
‘G’ allele at rs2007044 (located in intron 3 of CACNA1C), made more errors on a spatial 
working memory task than non-risk carriers in a risk allele dose dependent manner, an effect 
seemingly driven by the patient sample. The same risk allele was also associated with poorer 
working memory performance in independent patient samples, although not for the same task 
as was associated with the Irish case samples. No behavioral working memory associations 
were found with healthy participants in any sample. Finally, fMRI connectivity analysis of this 
risk allele in a subset of the discovery healthy participant sample suggested a gene dosage effect 
of the rs2007044 risk G allele on connectivity between the right DLPFC and multiple other 
cortical regions.  
As reviewed by Heyes et al., 42 the role of voltage-gated calcium channels in increasing risk of 
psychiatric disorders including SZ is currently the focus of intense investigation. Multiple 
intronic variants situated within the gene coding for CACNA1C (e.g. rs2007044, rs1006737, 
rs4765905) have been found to confer trans-diagnostic susceptibility to SZ, bipolar disorder 
and major depressive disorder3, 43-47. Timothy Syndrome, a disorder that includes cognitive 
deficits48 has also been associated with a missense mutation in CACNA1C. A previously 
identified intronic CACNA1C risk variant, rs100673746, 49, which is in moderately high LD with 
the PGC identified variant rs2007044 investigated here (LD r2=0.79), was also previously 
associated with poorer cognitive performance in SZ patients and controls50-52. In the first study 
that reports on the cognitive effects of rs2007044, the results we observe across three 
independent cohorts are highly consistent with those reported for rs1006737 by Hori et al.51 
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and Zhang et al,53 although one finding reported by Frazier et al54 reports the rs1006737 risk 
allele as being associated with an increase in cognitive function.  
Neural Mechanism of CACNA1C’s Role in Working Memory 
In seeking to establish the cortical basis of the CACNA1C rs2007044 risk allele effects on 
working memory, we analyzed fMRI data obtained during working memory task performance. 
Based on a previously reported methodology for assessing task dependent functional 
connectivity55, we found that CACNA1C risk genotype was associated with decreased 
connectivity between the dorsolateral prefrontal cortex and a distributed network of cortical 
regions (including the right cuneus, right anterior cingulate cortex, and left inferior frontal 
gyrus). This association suggested that during working memory task performance, risk carriers 
had difficulty with top down initiated cortical responses that resulted from dysconnectivity 
between the right DLPFC and other frontal and parietal regions. Although no genotype effects 
were evident for neural activation (as measured by BOLD activations), it has previously been 
suggested that functional connectivity between brain regions may represent a more sensitive 
intermediate phenotype in identifying neural circuits for schizophrenia risk variants compared 
to measures of neural activity56. Previous connectivity analysis for rs1006737 in working 
memory also reported altered functional connectivity between the right dorsolateral prefrontal 
cortex and the hippocampal formation, however the results obtained by Paulus et al.37, in which 
the rs1006737 risk allele (A) was associated with increased connectivity between the regions 
implicated, are inconsistent with the present study. Our results also differed from this previous 
study by suggesting that the pattern of altered connectivity between the right DLPFC and other 
cortical regions is more widespread. The reasons for this are uncertain and may relate to 
differences in either the SNP or working memory task studied. Whatever the cause, by again 
relating CACNA1C’s deleterious effects on working memory to pre-frontal dysconnectivity, 
our study highlights calcium channel deregulation as an important mechanism that contributes 
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to cognitive deficits. Finally, differences in in functional connectivity findings between studies 
are, as with other imaging analyses approaches, also likely to results from methodological 
differences38. As there is currently no gold standard method in functional connectivity research, 
these results should be interpreted with caution until they are replicated in an independent 
sample and shown to be consistent across different methodologies. 
Molecular Mechanisms 
CACNA1C codes for the α1c subunit of the L-type calcium channel which is particularly 
important to heart and brain function; in the brain, these channels are highly expressed in the 
granular cells of the dentate gyrus, a region synonymous with memory function57, 58. Although 
no significant findings in hippocampal regions are evident from the previous study, the α1c 
channel subunit encoded by CACNA1C is also widely expressed throughout other areas of the 
brain, including regions of altered connectivity identified in the present, and other, studies. 
These are predominantly expressed post-synaptically on the cell soma but also on the spines 
and shafts of neuron dendrites59. These channels support neuronal plasticity, through which 
they are involved with learning and memory. 
The molecular impact of rs2007044 has not yet been explored. For the rs1006737 SNP, risk 
genotype has been associated with increased CACNA1C mRNA expression in a dosage 
dependent manner in induced human neurons60 and in human dorsolateral prefrontal cortex 
cells61. In contrast, data from the Braineac database17 shows that the rs2007044 SNP can have 
opposite effects – that CACNA1C expression is decreased in the presence of one or more risk 
(G) rs2007044 alleles, although this is dependent on brain region. It is currently unclear, 
therefore, how the behavioral and cortical SNPs effects reported here might relate to difference 
in expression, and thereby to calcium subunit function; although developmental stage and type 
of cell are likely to influence this. 
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The two voltage gated calcium channel genes included in this analysis – CACNA1C and 
CACNB2 – both play a key role in synaptic transmission. Calcium channels are composed of 
different channel-forming subunits; each have multiple isoforms that determine specific 
cellular behavior62. Contrary to the assumption that genes coding for calcium subunits might 
influence the same cognitive functions, the two calcium channel SNPs included here were 
found to influence different domains of cognitive function – working memory and Theory of 
Mind respectively. To our knowledge, no other group to date has examined the effects of this 
CACNB2 variant rs7893279 (or any other CACNB2 variant) on cognition, and it was not 
possible to replicate these findings in the independent samples available (see discussion of 
limitations below). At the same time, CACNA1C has recently also been associated with effects 
on social information processing63. Therefore, whether this gene family has effects on more 
than one cognitive process warrants further investigation for potentially dissociable effects.  
Study Limitations 
Associations between common variants associated with risk for neuropsychiatric disorders are 
expected to be small and issues of both false positive and false negatives have been widely 
reported64. Here we sought to replicate our working memory finding in independent samples. 
While a significant effect of rs2007044 on working memory was observed in the Irish, Welsh 
and German samples, these associations were with different working memory tasks in each 
sample. In the Irish patient samples, the association was with spatial but not verbal working 
memory; in the Cardiff samples (consisting only of patients) the association observed was with 
a composite score, and in a follow up analysis with verbal but not spatial working memory; 
finally in the German samples, the association was with N-back (2-back) performance but not 
with a second composite measure, or the individual tasks from which the composite score was 
derived. These between sample differences between working memory tasks had not been 
hypothesized. It is possible that some measures may have differed in their sensitivity to gene 
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effects in different cohorts. What is clear, based on the post hoc analysis undertaken in the 
Cardiff samples, is that these differences cannot simply be attributed to verbal versus visuo-
spatial effects, as for example spatial effects were strongest in the Irish samples, but verbal 
effects in the Cardiff samples. Finally, the lack of association with other cognitive domains 
may further suggest that this association is specific to, or strongest for, the working memory 
domain. 
Given the importance of social cognition to understanding functional disability in SZ65, our 
inability to replicate the association in our discovery sample between two other risk loci and 
ToM is noteworthy. For example, in our discovery sample, based on a measure of ToM, we 
found that risk allele T carriers at rs7893279 scored lower on a ToM measure than non-carriers; 
and also that carriers of the C risk allele at rs1339227 scored higher on a ToM task than non-
carriers, both for the group as a whole and for the SZ/SZA sample considered separately. The 
rs1339227 SNP is ~50kb away from RIMS1; the closest gene in this region. The direction of 
this result was contrary to our expectation that risk allele dosage would be associated with 
poorer performance, and did not replicate in the Cardiff sample based on MSCEIT ‘managing 
emotions’ subtest performance; no social cognition measure was available in the German 
dataset. The lack of either the same measure or any measure of social cognition in sufficiently 
large datasets to enable replication of genetic findings related to social cognition is currently 
an important limitation for our field, especially considering our surprising findings here.  
Surprisingly, none of the SNPs identified as associated with cognitive performance in our 
discovery sample were linked to glutamate or dopaminergic transmission, given previous 
candidate gene studies (e.g. COMT, DTNBP1). It is of interest to note that in a recent 
bioinformatics study seeking to prioritize signals identified by the PGC,4 Pers et al.66 generated 
a gene set that overlapped substantially with the set reported here. This suggests that the 
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findings observed through this novel approach taken here are unlikely to be accounted for 
purely on the basis of an idiosyncratic approach to gene prioritization. 
Conclusion 
In conclusion, these data, based on previously identified SZ risk variants associated with 
synaptic transmission, provide some additional evidence for the role of CACNA1C in memory 
function already postulated in the literature. Furthermore, this association, we suggest, may 
result from patient risk carriers’ difficulty with top down initiated responses caused by 
dysconnectivity between the right DLPFC and other cortical regions. These deficits, and the 
potential role of calcium channel subunits in contributing to these, are not effectively addressed 
by current therapeutics. In this context, the approach to characterizing the functional effects of 
risk variants at both a behavioral and neural systems level, reported here, may assist future 
efforts to identify novel biological targets for treatment. 
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Figure Legends 
Figure 1. Effects of CACNA1C rs2007044 variant on right prefrontal connectivity during 
spatial working memory, global maximum approach, five outliers removed (n = 77)
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Tables 
Table 1. Neuropsychological Sample Participant Demographics and Subtest Scores 
  Healthy Participants Broad Diagnosis 
F (Healthy V Broad) Narrow Diagnosis F (Healthy V 
Narrow) 
Age, mean (SD) 35.82 (12.65) 43.00 (12.40) 81.02*** 42.30 (12.47) 59.36*** 
Male:Female (%) 44.5:55.5 66.2:33.8 49.96*** 70.4:29.6 67.01*** 
CPZ, mean (SD) mg/day  - 435.97 (453.17) - 498.18 (482.18) - 
SAPS mean (SD)  - 19.86 (19.30) - 21.86 (19.77) - 
SANS mean (SD)  - 23.58 (19.93) - 26.38 (19.99) - 
Education Years mean (SD) 15.64 (1.82) 12.95 (2.64) 184.28*** 12.73 (2.51) 191.51*** 
WTARR 41.90 (5.96) 33.52 (10.60) 179.36*** 32.77 (10.56) 194.60*** 
VERBIQ 118.45 (15.80) 92.06 (20.02) 374.27*** 90.36 (19.18) 433.73*** 
PERFIQ 117.78 (22.90) 91.20 (19.32) 356.35*** 89.83 (18.43) 393.58*** 
FSIQ, mean (SD) 119.68 (15.43) 92.07 (19.22) 429.87*** 90.31 (18.12) 515.19*** 
LM1 49.09 (10.10) 27.95 (12.35) 597.47*** 26.52 (12.37) 627.06*** 
LM2 31.75 (7.44) 15.34 (8.84) 688.13*** 14.40 (8.68) 732.18*** 
FACES1 38.93 (4.50) 33.79 (5.09) 128.61*** 33.65 (5.20) 124.70*** 
FACES2 39.56 (4.30) 35.04 (5.28) 85.29*** 35.04 (5.24) 85.14*** 
LNS 12.72 (3.13) 8.16 (3.40) 353.15*** 7.90 (3.44) 365.55*** 
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CANTAB SWM (errors) 19.04 (16.45) 43.05 (23.85) 189.727*** 43.86 (24.21) 204.20*** 
SART (reaction time) 32.38 (90.80) 445.29 (112.64) 126.04*** 443.83 (113.42) 122.46*** 
CPT d’Prime 2 Digit 3.82 (0.56) 2.69 (1.21) 19.95*** 2.67 (1.22) 19.79*** 
CPT d’Prime 3 Digit 3.35 (0.75) 3.35 (0.75) 46.37*** 1.91 (1.09) 46.72*** 
CPT d’Prime 4 Digit 2.25 (0.97) 1.14 (0.87) 45.76*** 1.12 (0.83) 48.38*** 
Eyes 26.47 (3.58) 21.21 (6.21) 101.45*** 20.48 (6.39) 120.43*** 
Hint 16.86 (1.79) 15.56 (3.31) 23.12*** 15.34 (3.48) 27.94*** 
IPSAQ – Externalizing Bias 1.52 (4.02) 1.49 (3.85) 0.54 1.39 (3.88) 0.34 
IPSAQ – Personalizing Bias 0.62 (0.24) 0.52 (0.29) 16.39*** 0.51 (0.28) 18.69*** 
FSIQ=Full-scale IQ; CPZ=Chlorpromazine equivalents; SAPS=Scale for the Assessment of Positive Symptoms; SANS=Scale for the Assessment 
of Negative Symptoms. *p<0.05 **p<0.01 ***p<0.001. 
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Table 2. Summary of significant findings from regression analyses in the discovery sample.  
rs ID Test  Sample n Mean (SD)         Bootstrap 95CI   
      
        
r2 B Lower Upper p 
rs2007044   AA (n=251) AG (n=330) GG (n=133)      
  
 All 714 35.17 (23.10) 37.43 (25.55) 41.61 (23.44) 0.006 2.600 0.635 4.535 0.012* 
 SWM Broad 557 38.82 (19.93) 41.91 (26.75) 47.51 (21.30) 0.012 3.634 1.133 6.184 0.006** 
  
 SZ/SZA 409 40.72 (22.66) 43.38 (25.76) 49.94 (21.25) 0.011 3.578 0.717 6.153 0.013* 
  
  Healthy  157 15.73 (12.27) 18.23 (16.42) 21.27 (17.31) 0.010 2.102 -0.632 4.891 0.138 
  
  
 
GG (n=6) GT (n=97) TT (n=416)      
 rs7893279  All 519 17.17 (1.72) 16.43 (2.20) 15.66 (3.25) 0.012 -0.772 -1.210 -0.337 0.003** 
 Hinting Broad 380 16.25 (0.96) 16.00 (2.37) 15.34 (3.55) 0.006 -0.643 -1.203 -0.122 0.021* 
  Task SZ/SZA 295 16.33 (1.15) 16.02 (2.38) 15.15 (3.74) 0.009 -0.826 -1.553 -0.147 0.017* 
    Healthy 139 19.00 (1.41) 17.31 (1.51) 16.59 (1.87) 0.052 -0.895 -1.448 -0.282 0.005** 
  
  
 
TT (n=63) TC (n=266) CC (n=224)      
 rs1339227  All 553 22.56 (6.36) 22.32 (6.17) 23.51 (5.83) 0.008 0.831 0.300 1.568 0.024* 
 Eyes Broad 392 20.20 (6.12) 20.51 (6.25) 22.48 (6.14) 0.018 1.272 0.235 2.228 0.007** 
  Test SZ/SZA 273 18.84 (6.39) 19.41 (6.25) 22.28 (6.36) 0.034 1.807 0.758 2.905 0.003** 
    Healthy 161 28.00 (2.21) 26.31 (3.62) 26.37 (3.56) 0.002 -0.251 -0.977 0.496 0.501 
SD=standard deviation; SWM=CANTAB Spatial Working Memory (Errors); SZ/SZA=Schizophrenia/Schizoaffective Disorder. Broad=broad 
sense psychosis diagnosis of bipolar disorder with psychotic features, major depressive disorder with psychotic features, or psychosis not otherwise 
specified; includes SZ/SZA patients. r2 represents the percentage of variance for each neuropsychological test score explained by the genotype; B: 
regression coefficient; p values uncorrected. 
Cosgrove et al. 
37 
 
Table 3. CACNA1C spatial working memory fMRI study:  participant demographics 
 Mean (SD) 
age  
Mean (SD) 
years 
education  
SWM mean 
(SD) 
accuracy  
SWM mean 
(SD) 
reaction 
time  
Gender (M:F) 
AA  
(N=25) 
30.88 
(11.02) 
16.96 
(3.84) 
64.80 
(6.86) 
9070.61 
(2332.96) 
15:10 
AG 
(N=42) 
27.86 
(7.10) 
17.75 
(3.24) 
62.17 
(10.90) 
8535.44 
(2063.93) 
15:27 
GG 
(N=17) 
29.00 
(10.30) 
17.66 
(2.87) 
64.94 
(4.63) 
8811.90 
(2296.80) 
7:10 
F or 2 F = 0.868 F = 0.438 F = 0.972 F = 0.475 2= 3.822 
p  0.424 0.647 0.383 0.624 0.148 
SWM = spatial working memory; F-statistic: one-way ANOVA comparing age, years of 
education, spatial working memory accuracy and reaction time between genotype groups; 2 
analysis: comparing gender by genotype group.  
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Table 4. Clusters, including individual peaks, showing significantly decreased functional 
connectivity with the right DLPFC with increasing rs2007044 risk alleles – global maximum 
approach, five outliers removed (n = 77) 
ap values are FWE-corrected for multiple comparisons at the cluster level 
 
 
 
Cluster Extent 
(voxels) 
p 
valuea 
Cluster peaks t-
value 
Z-
value 
Peak 
coordinates 
(MNI) 
1 888 <0.001 Right superior 
occipital gyrus 
4.92 
 
4.55 
 
21 -73 31 
   Right cuneus 4.65 
 
4.33 
 
15 -67 34 
   Right precuneus 4.45 
 
4.17 
 
9 -43 46 
2 121 
 
0.02 Right anterior 
cingulate cortex 
4.90 
 
4.53 
 
6 29 19 
